Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • ROOMS:

Aeglea BioTherapeutics to Participate in Upcoming Investor and Industry Conferences

AUSTIN, Texas, May 30, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that engineers next-generation human enzymes to provide solutions for diseases with unmet medical need, today announced that Anthony G. Quinn, M.B. Ch.B, Ph.D., president and chief executive officer of Aeglea, will participate in the following investor and industry conferences in June.

Jefferies 2019 Healthcare Conference

Date: Wednesday, June 5, 2019

Presentation Time:
8:30 a.m. ET

New York, NY


BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference

Date: Tuesday, June 25, 2019

Presentation Time:
11:40 a.m. ET

New York, NY


BIO International Convention

Date: Tuesday, June 4, 2019

Presentation Time:
3:15 p.m. ET

Philadelphia, PA

About Aeglea BioTherapeutics
Aeglea is a clinical-stage biotechnology company that engineers next generation human enzymes with enhanced properties and novel activity to provide solutions for diseases with unmet medical need. Aeglea is developing pegzilarginase, its lead investigational therapy, for the treatment of Arginase 1 Deficiency and in combination with an immune checkpoint inhibitor for small cell lung cancer. In addition, Aeglea has an active pipeline of other human enzyme-based approaches including programs for both Homocystinuria and Cystinuria. For more information, please visit

Media Contact:
David Calusdian
Sharon Merrill Associates

Investor Contact:
Joey Perrone
Senior Director, Finance & Investor Relations
Aeglea BioTherapeutics 

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.